Skip to content

Sonographic Differences in Brain Measurements Between Normal and Intrauterine Growth Restriction (IUGR) Fetuses

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01178619
Enrollment
0
Registered
2010-08-10
Start date
2010-09-30
Completion date
2012-08-31
Last updated
2013-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intra-uterine Growth Restriction

Keywords

IUGR fetuses, symmetrical IUGR, asymmetrical IUGR

Brief summary

Intrauterine growth restriction is being suspected in cases where the fetal estimated weight is less then the 10 th percentile for its gestational age. Abdominal circumference is the most influenced measurement in this cases. Head circumference on the other hand can be or not be influenced. Previous studies have shown that transverse cerebellar diameter (TCD) is constant to gestational age and is not influenced by IUGR.Other showed lower TCD in IUGR fetuses. We would like to study the differences in cerebellar, vermian and corpus callosum growth between normal to IUGR fetuses and between symmetrical and asymmetrical IUGR. In this observational study we will include pregnant women between 28-37 gestational week with a singleton otherwise normal pregnancies. We will measure the fetal TCD, vermian distances and the CC, abdominal circumference, head circumference and femur length. we will compeer these measurements according to the following groups:normal fetuses, symmetrical and asymmetrical IUGR.

Interventions

None listed

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL

Eligibility

Sex/Gender
ALL
Age
28 Weeks to 37 Weeks
Healthy volunteers
Yes

Inclusion criteria

* singleton, * 28-37 GA, * well dated pregnancy.

Exclusion criteria

* multifetal pregnancies, * no first trimester dating, * fetuses with known chromosomal or structural anomalies.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026